Filter Results:
(778)
Show Results For
- All HBS Web
(939)
- People (2)
- News (70)
- Research (778)
- Events (1)
- Multimedia (2)
- Faculty Publications (670)
Show Results For
- All HBS Web
(939)
- People (2)
- News (70)
- Research (778)
- Events (1)
- Multimedia (2)
- Faculty Publications (670)
←
Page 39 of 778
Results
Sort by
- 03 Mar 2015
- First Look
First Look: March 3
industries such as agriculture and biofuels. As GenapSys came closer to releasing its product, Esfandyarpour and his Senior Director of Operations and Strategy, Leila Rastegar (HBS '11), sat down to decide which of three business models... View Details
Keywords: Sean Silverthorne
- 10 Sep 2007
- Research & Ideas
High Note: Managing the Medici String Quartet
The panel consisted of Bob Frosch, who used to head NASA and R&D for GM; Vicki Sato, who was president of Vertex Pharmaceuticals and is now on the HBS faculty; and Peter Hanke, a conductor. These people have had a lot of experience... View Details
- April 1984
- Supplement
Johnson & Johnson (A): Philosophy & Culture, James Burke, Video
By: Francis Aguilar
James Burke, chairman and CEO of Johnson & Johnson, discusses the company's philosophy and culture, with particular emphasis on the significance of the Credo. View Details
Keywords: Organizational Culture; Values and Beliefs; Mission and Purpose; Management Teams; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Aguilar, Francis. "Johnson & Johnson (A): Philosophy & Culture, James Burke, Video." Harvard Business School Video Supplement 884-525, April 1984.
- 25 Feb 2014
- First Look
First Look: February 25
the weakening of democratic governance and the politics of decisions about industrial policy. Publisher's link: http://www.psupress.org/books/titles/978-0-271-05631-9.html August 2013 Research Policy Digital Dark Matter and the Economic... View Details
Keywords: Sean Silverthorne
- 03 Mar 2009
- First Look
First Look: March 3, 2009
presence of strategic interactions between content distributors and content providers. We provide a model of bargaining and price competition within these industries and show that whether or not a piece of content ends up exclusive to one... View Details
Keywords: Martha Lagace
- January 2015 (Revised July 2019)
- Case
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Case 515-010, January 2015. (Revised July 2019.) (Email mking@hbs.edu for a courtesy copy.)
- Research Summary
Overview
Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ... View Details
Keywords: Electricity; Prosumer; Smart Grid; Blockchain; Microgrid; Electric Vehicles; Batteries; Energy Storage; Ride-sharing; Smart Cities; Smart Buildings; Smart Meters; Demand Response; ＂GMOs,＂; Corporate Accountability; Responsibilities To Society; Environmental And Social Sustainability; Leadership & Corporate Accountability; Competitive Strategy; Innovation Strategy; Disruptive Innovation; Research and Development; Leadership; Environmental Sustainability; Energy Industry; Energy Industry; Energy Industry; Energy Industry; Energy Industry; Europe; Asia; United States
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- July 2013 (Revised November 2021)
- Module Note
Exploration vs. Exploitation
By: Willy Shih
This module note introduces James March's concept of exploration and exploitation, and the management challenge of balancing the allocation of resources to the two activities in the firm. The note also touches on the O'Reilly and Tushman paper on the ambidextrous... View Details
Keywords: Exploration And Exploitation; Exploitation; Research; Scientific Research; Product Commercialization; Innovation and Invention; Innovation and Management; Innovation Leadership; Innovation Strategy; Technological Innovation; Knowledge Acquisition; Growth and Development Strategy; Resource Allocation; Strategic Planning; Research and Development; Science-Based Business; Corporate Strategy; Knowledge Sharing; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Shih, Willy. "Exploration vs. Exploitation." Harvard Business School Module Note 614-004, July 2013. (Revised November 2021.)
- ←
- 39